I-13 Mike K Smith Implementing “best practice” in Pop PK modeling Wednesday 10:10-11:40 |
I-14 Tom Snowden A comparison of two model reduction methodologies for a QSP bone biology system with denosumab dosing. Wednesday 10:10-11:40 |
I-16 Eunjung Song Bayesian estimation of parameters in the pharmacokinetic model Wednesday 10:10-11:40 |
I-19 Andrew Stein Guiding dose selection of monoclonal antibodies using a new parameter (AFTIR) for characterizing ligand binding systems Wednesday 10:10-11:40 |
I-22 Claudia Suenderhauf The Basel Phenotyping Capsule as a tool for Quantifying Human metabolism in vivo – a tool to personalize physiological and semiphysiological Models Wednesday 10:10-11:40 |
I-29 Nadia Terranova The CICIL tool: a Java-based user-friendly application for the analysis of individual tumor size lesion dynamics Wednesday 10:10-11:40 |
I-35 Elena Tosca In vitro-in vivo correlation (IVIVC) population modeling for the in silico bioequivalence of a long-acting release formulation of Progesterone. Wednesday 10:10-11:40 |
I-48 Marc Vandemeulebroecke Graphical Principles Cheat Sheet Wednesday 10:10-11:40 |
I-72 Fan Zhang Structural and Practical Considerations in the Development of a Parent-metabolite Model Wednesday 10:10-11:40 |
I-73 Xiaoyan Zhang Population pharmacokinetic/pharmacodynamic modeling of plasma lyso-sphingomyelin response to enzyme replacement therapy olipudase alfa in patients with acid sphingomyelinase deficiency Wednesday 10:10-11:40 |
I-76 Meng Zhaoling Real World Evidence and Model-informed Drug Development – an antidiabetic drug cardiovascular outcome case study Wednesday 10:10-11:40 |
II-13 Thomas Frank LaTeX-based report writing: 10 years’ experience from Sanofi’s M&S group in Germany Wednesday 15:50-17:20 |
II-14 Sebastian Frechen A technical concept of automatic PBPK platform (re-)qualification in the Open Systems Pharmacology Suite (PK-Sim® and MoBi®) Wednesday 15:50-17:20 |
II-28 Nathalie Gobeau Model-based informed screening of antimalarial combinations Wednesday 15:50-17:20 |
II-31 Ignacio Gonzalez-Garcia Exploration of different scenarios using a drug exposure-response model of Lurbinectedin Wednesday 15:50-17:20 |
II-34 Sebastiaan Goulooze Supervised item response theory modelling improves prediction of iatrogenic withdrawal in children Wednesday 15:50-17:20 |
II-44 Richard Hooijmaijers ShinyMixR: A project-centric R/Shiny run management tool for nlmixr Wednesday 15:50-17:20 |
II-45 Andrew Hooker Computation of the geometric mean and variance of the AUC using polynomial chaos Wednesday 15:50-17:20 |
II-48 Hwi-yeol Yun Accurate and Precise Prediction of in-vivo hepatic clearance for drug with low KM Wednesday 15:50-17:20 |
II-75 Wojciech Krzyzanski Implementation of delay differential equations in NONMEM Wednesday 15:50-17:20 |
III-02 Nada Abla Geiser Development of PBPK drug models to support antimalarial combination strategy Thursday 09:55-11:30 |
III-43 Estelle Chasseloup Generation and Application of Avatars (Digital Twins) in Pharmacometric Modelling Thursday 09:55-11:30 |
III-51 Jason Chittenden PMDatR: A Pharmacometric Data Manipulation Package for R Thursday 09:55-11:30 |
III-64 Giuseppe De Nicolao Analysis of muscular biopsy distributional data in Duchenne Muscular Dystrophy treatment: a population approach Thursday 09:55-11:30 |
IV-20 Paolo Magni Evaluation of software tools for Bayesian estimation on population models: an update based on current software versions Thursday 15:10-16:40 |
IV-22 Victor Mangas-Sanjuan Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles Thursday 15:10-16:40 |
IV-36 Asbjørn Nøhr-Nielsen A review of fixed-dose combination approvals in the EU based on European public assessment reports (EPARs) Thursday 15:10-16:40 |
IV-37 Patrick Nolain PopkinR: a suite of Shiny applications focused on the pharmacometrics workflow Thursday 15:10-16:40 |
IV-54 Dimple Patel Using real world data to assess SGLT2 Inhibitor cardiovascular benefit and impacts of patient population characteristics Thursday 15:10-16:40 |
IV-55 Henning Schmidt Reproducible submission-ready Word reports based on open source tools Thursday 15:10-16:40 |
IV-67 Hanne Refsgaard Steps Towards a Robust Generic Method for Deconvolution Directly on Pharmacokinetic Profiles Thursday 15:10-16:40 |
IV-74 Oliver Sander Detecting and Analyzing 5x Sit-to-Stand Tests from Accelerometer Data Thursday 15:10-16:40 |